The growing need for addressing diagnosis and treatment needs for various gastrointestinal tract problems has boosted the clinical potential of duodenoscopes. They are particularly used in endoscopic retrograde cholangiopancreatography (ERCP). Growing demand for such tests among patient populations suffering from liver and pancreas diseases is key to expanding potential in the market. The prevalence of pancreaticobiliary disorders is a key trend boosting the utilization of duodenoscopes in ERCP.
Get Sample Copy of this Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=7163
Advances in techniques used and SOPs used in reprocessing of duodenoscopes are key to shaping the avenues in the duodenoscopes market. The trend can be ascribed to the fact that clinicians must be sure of the safety aspects. In recent years, medical regulatory agencies of various countries have kept a tab on the possible infections that may arise out of reuse. Growing number of players who are undertaking post-market surveillance studies is boosting the market. The rising risk of nosocomial infections due to cross-contamination is a key trend fuelling the relevance of such studies.
Improving the Standard of Care in GI Boosts Market
Over the past few years, healthcare providers in the gastroenterology are keen on improving the standard of care. This has nudged developers of medical systems to use state-of-the-art technologies to develop endoscopes. GI members alongside physicians to help them make the best utilization of new technologies that are integrated with products in the duodenoscopes market. Advances in videoscopes and the use of disposable distal cover are key technological advances. Advances made in guidewire techniques are also enabling increased the clinical utility of newly developed devices in the market.
Check Table of Contents of this Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=7163
Some of the players aiming at product innovations are Custom Ultrasonics, Inc., Endomed Systems GmbH, Hoya Corporation, KARL STORZ GmbH & Co. KG., and SonoScape Medical Corp..